OCTA in neurodegenerative optic neuropathies : emerging biomarkers at the eye-brain interface
© The Author(s), 2020..
OCTA imaging in optic neuropathies.
| Errataetall: |
ErratumIn: Ther Adv Ophthalmol. 2020 Oct 13;12:2515841420968685. - PMID 33134839 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Therapeutic advances in ophthalmology - 12(2020) vom: 08. Jan., Seite 2515841420950508 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Asanad, Samuel [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 28.09.2020 published: Electronic-eCollection ErratumIn: Ther Adv Ophthalmol. 2020 Oct 13;12:2515841420968685. - PMID 33134839 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1177/2515841420950508 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31496021X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31496021X | ||
| 003 | DE-627 | ||
| 005 | 20231225153853.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/2515841420950508 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1049.xml |
| 035 | |a (DE-627)NLM31496021X | ||
| 035 | |a (NLM)32923939 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Asanad, Samuel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a OCTA in neurodegenerative optic neuropathies |b emerging biomarkers at the eye-brain interface |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.09.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ErratumIn: Ther Adv Ophthalmol. 2020 Oct 13;12:2515841420968685. - PMID 33134839 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s), 2020. | ||
| 520 | |a OCTA imaging in optic neuropathies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Alzheimer’s disease | |
| 650 | 4 | |a Leber’s hereditary optic neuropathy | |
| 650 | 4 | |a Parkinson’s disease | |
| 650 | 4 | |a Wolfram Syndrome | |
| 650 | 4 | |a dominant optic atrophy | |
| 650 | 4 | |a erythrocyte mediated angiography | |
| 650 | 4 | |a glaucoma | |
| 650 | 4 | |a optic neuropathy | |
| 650 | 4 | |a optical coherence tomography angiography | |
| 650 | 4 | |a retinal blood flow | |
| 650 | 4 | |a schizophrenia | |
| 650 | 4 | |a vasomotion | |
| 700 | 1 | |a Mohammed, Isa |e verfasserin |4 aut | |
| 700 | 1 | |a Sadun, Alfredo A |e verfasserin |4 aut | |
| 700 | 1 | |a Saeedi, Osamah J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Therapeutic advances in ophthalmology |d 2018 |g 12(2020) vom: 08. Jan., Seite 2515841420950508 |w (DE-627)NLM286407124 |x 2515-8414 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2020 |g day:08 |g month:01 |g pages:2515841420950508 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/2515841420950508 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2020 |b 08 |c 01 |h 2515841420950508 | ||